Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women

J Am Geriatr Soc. 2003 Jul;51(7):985-90. doi: 10.1046/j.1365-2389.2003.51312.x.

Abstract

Objectives: To determine whether exercise training added to ongoing hormone replacement therapy (HRT) increases bone mineral density (BMD) in physically frail elderly women.

Design: Prospective controlled trial.

Setting: University-based research center.

Participants: Twenty-eight women on HRT, aged 75 and older with physical frailty.

Interventions: Participants were assigned to 9 months of supervised (EXER) or home (HOME) exercise. The EXER program started with physical therapy and gradually incorporated resistance and endurance training. The HOME program consisted of flexibility exercises.

Measurements: Changes in BMD and body composition.

Results: There were larger increases in lumbar spine BMD in response to EXER than with HOME (3.5% vs 1.5%, P =.048), with a trend for larger increases in total body BMD (1.5% vs 0.2%, P =.058). There were no significant between-group differences in hip BMD. The EXER group had decreases in weight (-2.2 +/- 0.3 kg, P =.010) and fat mass (-2.7 +/- 0.4 kg, P =.018) and increases in muscle strength (9-30%, P <.05).

Conclusion: In physically frail elderly women on HRT, relatively vigorous exercise training significantly increased lumbar spine BMD. The improved BMD and strength in response to exercise could reduce fracture risk in frail women already on HRT.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Body Composition / drug effects
  • Body Composition / physiology
  • Bone Density / drug effects*
  • Bone Density / physiology
  • Combined Modality Therapy
  • Estrogen Replacement Therapy*
  • Estrogens, Conjugated (USP) / therapeutic use*
  • Exercise Therapy*
  • Female
  • Fractures, Bone / etiology
  • Fractures, Bone / physiopathology
  • Fractures, Bone / prevention & control*
  • Frail Elderly*
  • Humans
  • Medroxyprogesterone Acetate / therapeutic use*
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / physiopathology
  • Osteoporosis, Postmenopausal / therapy*
  • Progesterone Congeners / therapeutic use*
  • Prospective Studies

Substances

  • Estrogens, Conjugated (USP)
  • Progesterone Congeners
  • Medroxyprogesterone Acetate